Table 1.
Demographic and medical characteristics characteristics at the time of first diagnosis with vulvar warts, vulvar intraepithelial neoplasia (VIN) of any grade, VIN 2 or a more severe lesion (VIN2+). All P-values by Fisher exact test except where noted.
| Characteristic | Vulvar Warts | Any VIN | VIN2+ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| HIV1+ (N = 612) | HIV− (N = 57) | P-value | HIV+ (N = 111) | HIV− (N = 5) | P-value | HIV+ (N = 55) | HIV− (N = 3) | P-value | |
| Age (years) | 0.0012 | 0.40 | 0.67 | ||||||
| <30 | 100 (16) | 21 (37) | 20 (18) | 2 (40) | 10 (18) | 1 (33) | |||
| 30–34 | 136 (22) | 6 (11) | 15 (14) | 0 (0) | 10 (18) | 0 (0) | |||
| 35–39 | 157 (26) | 14 (25) | 23 (21) | 2 (40) | 11 (20) | 1 (33) | |||
| 40–44 | 111 (18) | 12 (21) | 24 (22) | 1 (20) | 10 (18) | 1 (33) | |||
| >=45 | 108 (18) | 4 (7) | 29 (26) | 0 (0) | 14 (25) | 0 (0) | |||
| Ethnicity | 0.832 | 0.11 | 0.17 | ||||||
| White | 77 (13) | 8 (14) | 12 (11) | 2 (40) | 8 (15) | 2 (67) | |||
| Hispanic | 140 (23) | 15 (26) | 43 (39) | 0 (0) | 22 (40) | 0 (0) | |||
| Black | 380 (62) | 32 (56) | 53 (48) | 3 (60) | 23 (42) | 1 (33) | |||
| Other | 15 (2) | 2 (4) | 3 (3) | 0 (0) | 2 (4) | 0 (0) | |||
| Smoking | 0.132 | 0.45 | 0.76 | ||||||
| Never smoked | 145 (24) | 7 (12) | 30 (28) | 0 (0) | 12 (22) | 0 (0) | |||
| Former smoker | 101 (17) | 10 (18) | 18 (17) | 1 (20) | 10 (19) | 0 (0) | |||
| Current smoker | 361 (59) | 40 (70) | 60 (56) | 4 (80) | 32 (59) | 3 (100) | |||
| Intravenous drug use in prior 6 months | 0.35 | 1.00 | 1.00 | ||||||
| Yes | 34 (6) | 1 (2) | 6 (6) | 0 (0) | 2 (4) | 0 (0) | |||
| No | 573 (94) | 56 (98) | 102 (94) | 5 (100) | 52 (96) | 3 (100) | |||
| # of male sexual partners in prior 6 months | 0.012 | 0.01 | 0.32 | ||||||
| 0 | 174 (29) | 9 (16) | 40 (38) | 0 (0) | 16 (31) | 0 (0) | |||
| 1 | 332 (56) | 30 (53) | 56 (53) | 2 (40) | 31 (60) | 2 (67) | |||
| 2 | 54 (9) | 11 (19) | 7 (7) | 2 (40) | 3 (6) | 1 (33) | |||
| >=3 | 36 (6) | 7 (12) | 2 (2) | 1 (20) | 2 (4) | 0 (0) | |||
| CD4 (cells/cmm) | |||||||||
| >500 | 114 (19) | NA3 | 16 (15) | NA | 2 (4) | NA | |||
| 200–500 | 245 (42) | NA | 45 (42) | NA | 27 (51) | NA | |||
| <200 | 227 (39) | NA | 47 (44) | NA | 24 (45) | NA | |||
| HIV RNA level (/cmm) | |||||||||
| <=4000 | 226 (38) | NA | 50 (46) | NA | 17 (31) | NA | |||
| 4001–20000 | 105 (18) | NA | 20 (18) | NA | 15 (27) | NA | |||
| 20001–100000 | 134 (23) | NA | 23 (21) | NA | 9 (16) | NA | |||
| >100000 | 128 (22) | NA | 16 (15) | NA | 14 (25) | NA | |||
1
Human immunodeficiency virus
2
By Pearson’s chi-square test. All others by Fisher’s exact test.
3
Not applicable